1. Home
  2. BIAF vs GAME Comparison

BIAF vs GAME Comparison

Compare BIAF & GAME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIAF
  • GAME
  • Stock Information
  • Founded
  • BIAF 2014
  • GAME 2011
  • Country
  • BIAF United States
  • GAME United States
  • Employees
  • BIAF N/A
  • GAME N/A
  • Industry
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • GAME
  • Sector
  • BIAF Health Care
  • GAME
  • Exchange
  • BIAF Nasdaq
  • GAME Nasdaq
  • Market Cap
  • BIAF 21.4M
  • GAME 23.2M
  • IPO Year
  • BIAF 2022
  • GAME 2009
  • Fundamental
  • Price
  • BIAF $1.24
  • GAME $0.89
  • Analyst Decision
  • BIAF Strong Buy
  • GAME Strong Buy
  • Analyst Count
  • BIAF 1
  • GAME 3
  • Target Price
  • BIAF $6.00
  • GAME $3.67
  • AVG Volume (30 Days)
  • BIAF 102.5K
  • GAME 322.8K
  • Earning Date
  • BIAF 11-14-2024
  • GAME 11-14-2024
  • Dividend Yield
  • BIAF N/A
  • GAME N/A
  • EPS Growth
  • BIAF N/A
  • GAME N/A
  • EPS
  • BIAF N/A
  • GAME N/A
  • Revenue
  • BIAF $9,367,785.00
  • GAME $94,529,043.00
  • Revenue This Year
  • BIAF $302.41
  • GAME $102.07
  • Revenue Next Year
  • BIAF $15.00
  • GAME $17.85
  • P/E Ratio
  • BIAF N/A
  • GAME N/A
  • Revenue Growth
  • BIAF 2813.87
  • GAME 159.34
  • 52 Week Low
  • BIAF $1.20
  • GAME $0.65
  • 52 Week High
  • BIAF $3.62
  • GAME $2.25
  • Technical
  • Relative Strength Index (RSI)
  • BIAF 36.67
  • GAME 53.05
  • Support Level
  • BIAF $1.21
  • GAME $0.79
  • Resistance Level
  • BIAF $1.37
  • GAME $1.10
  • Average True Range (ATR)
  • BIAF 0.08
  • GAME 0.11
  • MACD
  • BIAF 0.01
  • GAME -0.00
  • Stochastic Oscillator
  • BIAF 17.50
  • GAME 40.00

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About GAME GameSquare Holdings Inc.

GameSquare Holdings Inc is a vertically integrated, digital media, entertainment and technology company that connects brands with gaming and youth culture audiences. The company's end-to-end platform includes Gaming Community Network (a "GCN"), a digital media company focused on gaming and esports audiences, Swingman LLC dba as Zoned, a gaming and lifestyle marketing agency, and Code Red Esports Ltd. The company's geographical segment includes the United Kingdom, the USA, and Spain. The company generates the majority of its revenue from the USA. The company's sources of revenue consist of Teams, Agency, and SaaS + Advertising.

Share on Social Networks: